Professor Alain Brunet : The Originator of a Revolutionary Protocol for PTSD
Professor Alain Brunet is the driving force behind a groundbreaking therapeutic advancement in the field of psychiatry. After 30 years of research and international collaborations, he developed and fine tuned an innovative therapeutic protocol called Reconsolidation Therapy™ that reduces the emotional impact of traumatic memories, offering hope to millions suffering from PTSD.
He now teaches his therapeutic protocol to mental health professionals worldwide, enabling them to more efficiently care for an increasing number of patients in need.
- Teaching, Training, and Supervision
Reducing the Strength of Traumatic Memories
The Reconsolidation Therapy™ protocol by Professor Alain Brunet and his team modifies how traumatic memories are re-stored in the brain, allowing for a significant reduction in their emotional burden.
Through a precise recall protocol that combines the reactivation of the memory with the administration of a beta-blocker, patients report a noticeable improvement in their symptoms after just a few sessions.
This revolutionary approach, based on an animal model, rests on a sound understanding of brain and memory functioning. By acting on the mechanisms of reconsolidation, the treatment reduces the strength of traumatic memories, offering patients the opportunity to regain control over their lives and achieve lasting mental well-being.
A Turning Point in PTSD Treatment
Reconsolidation Therapy™, born from scientific advances in neuroscience, represents a revolution in the treatment of trauma- and stressor-related disorders. This innovative approach, grounded in cutting-edge clinical methods, combines the use of specific a generic medication with gentle trauma work with a therapist, aiming to alleviate the painful aftermath of traumatic events such as accidents, assaults, or natural disasters.
Scientific Validation of the Method's Efficacy
Scientific studies conducted worldwide have demonstrated the efficacy and effectiveness of this treatment method, showing a significant reduction in symptoms for over 70% of treated patients after just six once-a-week treatment sessions. This innovative treatment, which combines the use of a beta-blocker with brief face-to-face (or remote) therapy work, marks a turning point in the care of PTSD patients.
At the forefront of this therapeutic advance is Professor Alain Brunet, whose research and discoveries have laid the foundation for a new treatment paradigm in psychiatry. Professor Alain Brunet has developed a therapeutic approach that durably reduces the emotional impact of traumatic memories, thus offering tangible hope to the millions affected by PTSD worldwide.